• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血浆置换对高血压患者淋巴细胞能量酶的影响]

[Effects of plasmapheresis on lymphocytic energy enzymes in hypertension].

作者信息

Kuznetsov S V, Kim I S, Ananchenko V G

出版信息

Sov Med. 1990(5):25-8.

PMID:2389196
Abstract

Cytochemistry of peripheral blood lymphocyte enzymes was studied in 58 patients with State II essential hypertension (36 of these were treated with traditional hypotensive therapy and 22 with plasmapheresis + drug therapy). alpha-GPDH, LDH, and acid phosphatase activities were found reduced in these patients. The degree of the enzymic activity reduction (SDH included) depended on the disease standing and family history of patients. Plasmapheresis elevated the activities of energy enzymes and reduced arterial pressure, i.e. these parameters were in inverse correlation. In the patients treated by routine hypotensive therapy energy enzymes' activity was unchanged, despite the clinical effect.

摘要

对58例Ⅱ期原发性高血压患者(其中36例接受传统降压治疗,22例接受血浆置换+药物治疗)的外周血淋巴细胞酶进行了细胞化学研究。发现这些患者的α-甘油磷酸脱氢酶、乳酸脱氢酶和酸性磷酸酶活性降低。酶活性降低的程度(包括琥珀酸脱氢酶)取决于患者的病情和家族史。血浆置换提高了能量酶的活性并降低了动脉血压,即这些参数呈负相关。在接受常规降压治疗的患者中,尽管有临床效果,但能量酶的活性没有变化。

相似文献

1
[Effects of plasmapheresis on lymphocytic energy enzymes in hypertension].[血浆置换对高血压患者淋巴细胞能量酶的影响]
Sov Med. 1990(5):25-8.
2
[Treatment of patients with hypertonic disease with plasmapheresis].[采用血浆置换术治疗高渗性疾病患者]
Klin Med (Mosk). 1989 Jul;67(7):40-3.
3
[Clinical and hemodynamic evaluation of the effectiveness of plasmapheresis in high arterial hypertension refractory to drug treatment agents].[血浆置换术治疗药物治疗无效的重度高血压的临床及血流动力学疗效评估]
Ter Arkh. 1988;60(5):80-5.
4
[Plasmapheresis in the treatment of patients with hypertension].
Sov Med. 1991(10):20-2.
5
[Hypotensive effect of plasmapheresis in patients with severe symptomatic arterial hypertension of renal origin].
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1987;10(1):87-90.
6
[Clinico-immunological assessment of the effectiveness of plasmapheresis in the combined therapy of patients with high arterial hypertension].[血浆置换术在重度高血压患者联合治疗中的临床免疫疗效评估]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1987;10(1):25-9.
7
[Evaluation of the effectiveness of plasmapheresis in the treatment of patients with severe arterial hypertension].[血浆置换治疗重度高血压患者的疗效评估]
Klin Med (Mosk). 1987 Oct;65(10):20-5.
8
[Treatment of refractory arterial hypertension by plasmapheresis].[血浆置换治疗顽固性动脉高血压]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1988;11(1):71-7.
9
[Use of plasmapheresis in the treatment of patients with severe arterial hypertension refractory to drug therapy].[血浆置换在药物治疗难治性重度动脉高血压患者中的应用]
Ter Arkh. 1988;60(6):60-4.
10
[Cytochemical parameters of lymphocytes in non-coronarogenic myocardial diseases].[非冠状动脉性心肌病中淋巴细胞的细胞化学参数]
Sov Med. 1991(3):5-7.